Clinical Trial Update: Abemaciclib and Letrozole to Treat Endometrial Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the combination of abemaciclib and letrozole for endometrial cancer. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• FEMARA (letrozole)
• VERZENIO (ABEMACICLIB)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Endometrial Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING